Parallax Volatility Advisers’s Juno Therapeutics, Inc. JUNO Stock Holding History

Parallax Volatility Advisers’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-40,000	Closed	-$1.83M	–	5293
2017 Q4	$1.83M	Buy	+40,000	New	+$2M	﹤0.01%	947
2017 Q1	–	Sell	-140,000	Closed	-$2.64M	–	5150
2016 Q4	$2.64M	Buy	140,000 +47,000	+51%	+$1.15M	0.01%	851
2016 Q3	$2.79M	Sell	93,000 -30,000	-24%	-$933K	0.01%	889
2016 Q2	$4.73M	Buy	123,000 +93,000	+310%	+$3.86M	0.01%	639
2016 Q1	$1.14M	Buy	30,000 +8,100	+37%	+$282K	﹤0.01%	1134
2015 Q4	$963K	Sell	21,900 -13,100	-37%	-$650K	﹤0.01%	1297
2015 Q3	$1.42M	Buy	+35,000	New	+$1.53M	﹤0.01%	1160

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Parallax Volatility Advisers's JUNO Position: Q4 2017 in Review

Parallax Volatility Advisers sold out of Juno Therapeutics, Inc. (JUNO) in Q4 2017, closing a stake of 1,246 shares — an estimated $62.2K sold.

Parallax Volatility Advisers first reported a position in JUNO in Q2 2015 and held it in 3 quarters. The position peaked at $651K in Q2 2015. 237 funds tracked by Wall St. Rank hold JUNO as of Q4 2017.

Parallax Volatility Advisers reported no remaining Juno Therapeutics, Inc. position as of Q4 2017 after selling out during the quarter.
Parallax Volatility Advisers sold 1,246 Juno Therapeutics, Inc. shares in Q4 2017, an estimated $62.2K.
Parallax Volatility Advisers first reported a position in Juno Therapeutics, Inc. in Q2 2015 and held it in 3 quarters.
Parallax Volatility Advisers's Juno Therapeutics, Inc. position peaked at $651K in Q2 2015.
237 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q4 2017.

Based on Parallax Volatility Advisers's 13F filing for Q4 2017, filed 14 Feb 2018.